Table 4.
Correlation analysis of the expression levels of P. gingivalis, CXCL2 and TANs between OSCC patients deaths
| Variable | Mdel1 | Model2 | |||
|---|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | ||
| P. gingivalis | Weak | 1.000 | 1.000 | ||
| Strong | 11.547 (2.758–48.346) | < 0.001 | 7.128 (1.562–32.537) | 0.011 | |
| CXCL2 | Weak | 1.000 | 1.000 | ||
| Strong | 11.906 (3.622–39.142) | < 0.001 | 9.519 (2.619–34.604) | < 0.001 | |
| TANs | Weak | 1.000 | 1.000 | ||
| Strong | 10.081 (3.067–33.138) | < 0.001 | 8.092 (2.253–29.063) | 0.001 | |
P. gingivalis, Porphyromonas gingivalis; CXCL2, C-X-C motif chemokine ligand 2; TANs, Tumour-associated neutrophils. No indicators were adjusted in Model 1, indicators such as T stage and recurrence were adjusted in Model 2
*p < 0.05; **p < 0.01, ***p < 0.001